Disturbed gut virome with potent interferonogenic property in systemic lupus erythematosus

被引:10
|
作者
Chen, Beidi [1 ,2 ]
Cao, Jiabao [3 ,4 ]
Liu, Wei [1 ]
Zhang, Yuqing [3 ,4 ]
Liu, Yudong [1 ]
Wang, Min [1 ]
Xiao, Fei [5 ]
Ma, Jie [5 ]
Wang, Jun [3 ,4 ]
Zhang, Xuan [1 ]
机构
[1] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Natl Ctr Gerontol,Dept Rheumatol, Beijing 100730, Peoples R China
[2] Peking Univ Third Hosp, Div Rheumatol & Immunol, Beijing 100191, Peoples R China
[3] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China
[4] Univ Chinese Acad Sci, Beijing 100101, Peoples R China
[5] Chinese Acad Med Sci, Beijing Hosp, Inst Geriatr Med, Beijing Inst Geriatr,Key Lab Geriatr,Natl Ctr Gero, Beijing 100730, Peoples R China
基金
中国国家自然科学基金;
关键词
Systemic lupus erythematosus; Gut virome; Virus-like particles; Interferon-a; VIRUS; RISK;
D O I
10.1016/j.scib.2023.01.021
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Accumulating evidence suggests an essential role of disturbed gut microbiota in the etiopathogenesis of systemic lupus erythematosus (SLE), but it remains unclear as to gut virome. In this study, fecal virus-like particles (VLPs) isolated from 76 non-treated SLE patients and 75 healthy controls were subjected to gut virome profiling. The proportion of bacteriophages was significantly elevated in the SLE gut, and the altered viral taxa were correlated with clinical parameters. Gut virome and bacteriome were closely associated with each other in SLE patients. The combination of gut viral and bacterial markers displayed better performance in distinguishing SLE patients from healthy controls. Further, VLPs from non-treated SLE patients promoted interferon-a production in an epithelial cell line and human immune cells. Intriguingly, the interferon-stimulatory capacity diminished in VLPs from post-treated SLE patients. Our findings may shed novel insights into SLE pathogenesis. Further in-depth understanding of gut virome might help develop future biomarkers and therapeutics for SLE patients. & COPY; 2023 Science China Press. Published by Elsevier B.V. and Science China Press. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:295 / 304
页数:10
相关论文
共 50 条
  • [31] Systemic lupus erythematosus
    Johnson, B
    AMERICAN JOURNAL OF NURSING, 1999, 99 (01) : 40 - 41
  • [32] Systemic lupus erythematosus
    D'Cruz, David P.
    Khamashta, Munther A.
    Hughes, Graham R. V.
    LANCET, 2007, 369 (9561): : 587 - 596
  • [33] Systemic Lupus Erythematosus
    Aringer, M.
    Schneider, M.
    AKTUELLE RHEUMATOLOGIE, 2017, 42 (04) : 285 - 290
  • [34] Systemic lupus erythematosus
    Kneitz, C
    Goebeler, M
    Tony, HP
    INTERNIST, 2003, 44 (12): : 1557 - 1573
  • [35] Systemic lupus erythematosus
    D'Cruz, DP
    BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7546): : 890 - 894B
  • [36] Systemic lupus erythematosus
    Steinsson, K
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1998, 27 (04) : 318 - 318
  • [37] SYSTEMIC LUPUS ERYTHEMATOSUS
    HILL, LC
    BRITISH MEDICAL JOURNAL, 1957, 2 (SEP21): : 655 - 660
  • [38] SYSTEMIC LUPUS ERYTHEMATOSUS
    不详
    POSTGRADUATE MEDICINE, 1968, 44 (03) : 23 - &
  • [39] Systemic lupus erythematosus
    Lisnevskaia, Larissa
    Murphy, Grainne
    Isenberg, David
    LANCET, 2014, 384 (9957): : 1878 - 1888
  • [40] Systemic lupus erythematosus
    Jimenez, Lidia Maronas
    Garcia-Rodrigo, Carlota Gutierrez
    Alonso, Rafael Muley
    Tapia, Aurora Guerra
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2014, 112 (05): : 478 - 480